TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Dr. Martens Plc ( (GB:DOCS) ).
Dr. Martens Plc has announced that its total issued ordinary share capital consists of 965,229,918 shares, each with one voting right, and no shares are held in Treasury. This information is crucial for shareholders to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:DOCS) stock is a Hold with a £0.85 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.
Spark’s Take on GB:DOCS Stock
According to Spark, TipRanks’ AI Analyst, GB:DOCS is a Neutral.
Dr. Martens Plc scores a 67, reflecting a balance of mixed financial performance, challenging technical indicators, and reasonable valuation. The company’s strong cash flow and strategic corporate events provide optimism, though declining revenue and weak technical signals pose concerns. The recent corporate events bolster stakeholder confidence, contributing to a moderately positive outlook.
To see Spark’s full report on GB:DOCS stock, click here.
More about Dr. Martens Plc
Dr. Martens Plc is a prominent player in the footwear industry, known for its iconic boots and shoes. The company focuses on producing durable and fashionable footwear that appeals to a wide range of consumers globally.
Average Trading Volume: 1,379,858
Technical Sentiment Signal: Strong Sell
Current Market Cap: £530.1M
See more insights into DOCS stock on TipRanks’ Stock Analysis page.